Geisinger Commonwealth School of Medicine to host free community education event: Medical Marijuana in Pennsylvania

SCRANTON – As part of its ongoing series of community health education programs, Geisinger Commonwealth School of Medicine will host “Medical Marijuana in Pennsylvania” on Thursday, July 27, at 5:30 p.m. at the school’s Medical Sciences Building at 525 Pine St.
This session will cover: 
•       Evidence for benefits of medical marijuana use
•       The risks of medical marijuana use
•       How physicians certify patients for medical marijuana use
Victor O. Kolade, MD, MS, clinical professor of medicine, will discuss the latest research on medical marijuana and explore data regarding its efficacy for certain health conditions. There will also be time for questions.
Board certified in internal medicine, Dr. Kolade is an internist at Guthrie Robert Packer Hospital in Sayre.
To register visit go.geisinger.edu/communityedseries.
Continuing education credits (CEUs) are available.

About Geisinger

Geisinger is among the nation’s leading providers of value-based care, serving 1.2 million people in urban and rural communities across central and northeastern Pennsylvania. Founded in 1915 by philanthropist Abigail Geisinger, the nonprofit system generates more than $8 billion in annual revenues across 163 care sites — including 10 hospital campuses — and Geisinger Health Plan, with more than half a million members in commercial and government plans. Geisinger College of Health Sciences educates more than 5,000 medical professionals annually and is conducting more than 1,400 clinical research studies. With more than 27,000 employees, including 1,800 employed physicians and 5,200 registered nurses, Geisinger is among Pennsylvania’s largest employers, having an estimated economic impact of $16.8 billion on the state’s economy. In 2024, Geisinger joined Risant Health, a nonprofit charitable organization created to expand and accelerate value-based care across the country. Learn more at geisinger.org or follow on Facebook, Instagram and LinkedIn.